Skip to main content

Sias to Acquire Lab Equipment Firm Xiril

NEW YORK (GenomeWeb News) – Swiss liquid handling systems firm Sias has inked an agreement to acquire laboratory equipment and software firm Xiril.

The deal is expected to be completed at the end of this month and will provide Sias with products focused on the diagnostic and DNA analysis markets, the Hombrechtikon, Switzerland-based firm said in a statement released yesterday. Financial terms of the deal were not disclosed, but Sias said that it would pay for the acquisition with company stock.

Sias added that the acquisition enables it to maintain rapid growth, while increasing its market share and sharpening its "competitive edge in a market that still has enormous potential."

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.